STAT3 and neoplasm: As pericyte depletion was known to induce angiogenic growth and metastatic spread of disease, we speculated that STAT3 activation could be driving tumor angiogenesis and metastasis at survival endpoint in 30200 model as a result of cediranib-induced increased IL6 secretion and downstream activation of endothelial cells.